News
-
According to Adherium, the FDA has granted 510(k) clearance for OTC sales of the company’s Hailie adherence monitoring sensor for use with several MDIs for the treatment of asthma. In March 2018, the FDA granted… Read more . . .
-
I am sure that I was not alone to conclude after the 2018 Respiratory Drug Delivery Conference that the most profoundly important session was “Exploring the Benefits of Smart Inhalers on Public Health.” And I… Read more . . .
-
After meeting with the FDA regarding the clinical program for US approval of its Penthrox methoxyflurane inhaler, Medical Developments International (MVP) said that it expects to receive a clinical hold letter from the agency within… Read more . . .
-
Copley Scientific has announced the launch of an upgraded NGI Assistant for automated drug recovery from NGI cascade impactors for inhaler testing. According to Copley, the new model features a simplified interface and shorter cycle… Read more . . .
-
The FDA has issued a notice that it has reopened the comment period for the “Metered Dose Inhaler and Dry Powder Inhaler Drug Products—Quality Considerations; Draft Guidance for Industry,” which was published in April, 2018.… Read more . . .
-
Windtree Therapeutics said that it has completed design verification of a new version of its aerosol delivery system (ADS) for Aerosurf inhaled KL4 surfactant for the treatment of respiratory distress syndrome (RDS) in premature infants… Read more . . .
-
Nanopharm Limited has announced an agreement with US-based Sciarra Laboratories that will pair Nanopharm’s SmartTrack OINDP development services with Sciarra’s GMP metered dose inhaler manufacturing services. Together, Nanopharm and Sciarra will comprise a CDMO with… Read more . . .
-
Pneuma Respiratory, which is developing a digital soft mist inhaler, announced that it has completed a Series A financing round that raised $8.3 million. The company’s Pneumahaler device is a breath activated digital SMI that… Read more . . .
-
Pulmatrix has announced that the 3rd part of its Phase 1/1b study of Pulmazole (PUR1900) itraconazole DPI for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma has been completed and “successfully achieved… Read more . . .
-
3M Drug Delivery Systems has announced that its Proventil HFA albuterol MDI, which is marketed and distributed by Merck, now includes a top-mounted dose indicator. The FDA approved an sNDA for Proventil HFA with the… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland